Patient with recurrent glioblastoma began novottf therapy on (b)(6) 2014.On (b)(6) 2014 a novocure device support specialist was informed by the son that the patient passed away on (b)(6) 2014.The patient was admitted to hospital for pneumonia prior to death but the family did not know the official cause of death.Prescribing physician was contacted for additional information with no response.Cause of death is unknown.No adverse events associated with device use were reported.The last of novotff therapy was not known until the equipment was returned to novocure and logfiles downloaded on (b)(4) 2014.Per logfile review, last device use was (b)(6) 2014 at 05:37 and device was functioning as per normal operating parameters.
|